This post is from a suggested group
Innovation and Early Diagnosis Drive Expansion of the Antiglaucoma Drug Market
Market Overview
The Antiglaucoma Drug Market is expanding rapidly as awareness of glaucoma—a leading cause of irreversible blindness—increases globally. Glaucoma occurs when elevated intraocular pressure (IOP) damages the optic nerve, necessitating timely medical intervention to preserve vision.
Rising elderly populations and improved diagnostic capabilities have contributed to growing demand for safe and effective IOP-lowering drugs. Additionally, combination therapies and sustained-release formulations are transforming patient compliance and treatment efficacy.
Key Market Drivers
Increasing Glaucoma Prevalence: Ageing demographics and sedentary lifestyles contribute to higher incidence.